The stem cell therapy market is expected to grow from US$ 2,278.49 million in 2022 to US$ 6,206.89 million by 2028; it is estimated to grow at a CAGR of 18.2% from 2022 to 2028.
Stem cells are preliminary body cells from which all other cells with specialized functions are generated. Under a controlled environment in the body or a clinical laboratory, these cells divide to form more cells, called daughter cells. With the advent of modern health science, these cells have been demonstrated to play a major role in understanding the occurrence of diseases, the generation of advanced regenerative medicines, and the discovery of other drugs. Stem cells are formed in embryos, bone marrow, body fats, and umbilical cord blood, among others.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Stem Cell Therapy Market: Strategic Insights
Market Size Value in US$ 2,278.49 million in 2022 Market Size Value by US$ 6,206.89 million by 2028 Growth rate CAGR of 18.2% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Stem Cell Therapy Market: Strategic Insights
| Market Size Value in | US$ 2,278.49 million in 2022 |
| Market Size Value by | US$ 6,206.89 million by 2028 |
| Growth rate | CAGR of 18.2% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Increasing Organic and Inorganic Strategies by Key Players
The key market players are taking up various organic and inorganic strategies, including mergers and acquisitions, expansions, and new product launches, to stay competitive in the market.
- In October 2022, Medipost (CEO Won-Il Oh) announced the launch of its Contract Development and Manufacturing Organization (CDMO) business for cell and gene therapy products in Korea. The company announced its new GMP facilities will house 10 cleanrooms and production facilities equipped with up-to-date equipment exclusively for CDMO.
- In December 2019, Lineage Cell Therapeutics and AgeX Therapeutics, in partnership, registered a US patent for the method of generating induced pluripotent stem cells.
- In June 2021, Allogene Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ALLO-605, the Company’s next-generation AlloCAR T therapy targeting BCMA for the treatment of relapsed or refractory multiple myeloma. The FDA granted Fast Track designation based on the potential of ALLO-605 to address the unmet need for patients who have failed other standard multiple myeloma therapies.
Thus, many organic and inorganic strategies in the stem cell therapy market enable healthcare professionals to provide improved services.
Lucrative Regions in Stem Cell Therapy Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Stem cell therapy has been widely investigated across the world. Stem cells are mainly used to replace dying cells and reconstruct damaged tissues. Based on the results of extensive stem cell research conducted so far, many scientists have claimed that these cells could probably be utilized to generate cures and treatments for diseases such as cancer and cardiovascular disease. Newly developed stem cell therapies involve replacing disease-causing cells with stem cells. Many potential treatments involving stem cells are in different phases of clinical trials. The FDA has also approved a few stem cell therapies involved in treating complications related to stem cell transplants. In September 2021, the US Food and Drug Administration (FDA) announced approval for "Ruxolitinib" for treating "graft-versus-host-disease" (GVHD) in patients aged 12 and above. Ruxolitinib provides a patient new hope that suffers from fatal complications associated with stem cell transplants.- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Researchers are further investigating the use of stem cell therapy in treating autoimmune disorders. For example, stem cells can turn into the cells of damaged organs and are used in treating autoimmune diseases. Treatment is carried out using mesenchymal stem cells or fetal stem cells. Hematopoietic stem cells are currently used for treating more than 80 medical conditions, including immune system diseases; blood disorders; neurological disorders; metabolic disorders; genetic disorders; and cancer types such as leukemia and lymphoma.
Type Insights
Based on type, the stem cell therapy market is segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and other stem cell therapy. The adult stem cell therapy segment held the largest market share in 2021. However, the induced pluripotent stem cell therapy segment is anticipated to register the highest CAGR during the forecast period (2022–2028).
Treatment Insights
Based on treatment, the global stem cell therapy market is bifurcated into allogeneic and autologous. The allogenic segment held the larger stem cell therapy market share in 2021. Moreover, the autologous segment is expected to grow at the highest CAGR during the forecast period.
Application Insights
In terms of application, the stem cell therapy market is divided into musculoskeletal, dermatology, cardiology, drug discovery and development, and other applications. The drug discovery and development segment held the largest market share in 2021, and it is expected to register the highest CAGR during the forecast period.
Stem Cell Therapy Market, by Type – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
End User Insights
Based on end user, the stem cell therapy market is bifurcated into academic & research institutes and hospitals & clinics. The academic & research institutes segment held a larger market share in 2021, and the same segment is expected to register a higher CAGR in the market during the forecast period (2022–2028).
Companies in the stem cell therapy market majorly adopt inorganic strategies such as mergers and acquisitions. A few of the recent key developments in the market are listed below.
- In June 2021, the USFDA granted Fast Track designation to ALLO-605, the next-generation AlloCAR T therapy offered by Allogene Therapeutics, Inc., targeting BCMA for the treatment of relapsed or refractory multiple myeloma. The designation was granted on the basis of the potential of ALLO-605 to address the unmet needs of patients who didn’t respond to other standard multiple myeloma therapies.
- In June 2021, MEDIPOST announced that the company has expanded the production facilities for its knee osteoarthritis stem cell products, CARTISTEM and SMUP-IA-01, and will start preparing for GMP (Good Manufacturing Practice) certification.
- In September 2022, Caladrius Biosciences, Inc. and Cend Therapeutics, Inc. announced that the proposed merger of the two companies has closed following the approval of Caladrius’ stockholders on September 13, 2022. The merged company will operate as Lisata Therapeutics, Inc. and will focus primarily on advancing its CendR Platform technology product candidates in a range of oncology indications, in addition to Caladrius’ existing development programs.
- In March 2019, BioTime, Inc acquired Asterias Biotherapeutics, Inc. which deals in regenerative medicines to consolidate its stem cell therapies product portfolio.
Company Profiles
- MEDIPOST
- Pharmicell Co., Inc.
- RichSource
- BioTime, Inc.
- Mesoblast Limited
- Holostem Terapie Avanzate Srl
- U.S. Stem Cell, Inc.
- Caladrius Biosciences, Inc.
- TiGenix NV
- AlloSource
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Treatment, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Stem cells are preliminary body cells from which all other cells with specialized functions are generated. Under controlled environment in the body or a clinical laboratory, these cells divide to form more cells called daughter cells. Due to the advent of modern health science, these cells play a major role in understanding the occurrence of diseases, generation of advanced regenerative medicines, and drug discovery. There are certain sources such as embryo, bone marrow, body fats, and umbilical cord blood amongst others, where stem cells are generated.
Increasing research activities related to stem cell therapy for effective disease management and growing prevalence of cancer are the most significant factors responsible for the overall market growth.
Based on type segment, the adult stem cell therapy segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
Based on the treatment, allogenic segment took the forefront leaders in the worldwide market by accounting largest share in 2021.
Academic & Research institutes segment dominated the global stem cell therapy market and accounted for the largest market share during the forecast period of 2022-2028.
MEDIPOST, RichSource, BioTime, Inc., Mesoblast Limited, Holostem Terapie Avanzate Srl, U.S. Stem Cell, Inc., TiGenix NV, AlloSource, NuVasive Inc, JCR Pharmaceuticals Co. Ltd. and among others are among the leading companies operating in the stem cell therapy market.
Global stem cell therapy market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Stem Cell Therapy Market – By Type
1.3.2 Global Stem Cell Therapy Market – By Treatment
1.3.3 Global Stem Cell Therapy Market – By Application
1.3.4 Global Stem Cell Therapy Market – By End User
1.3.5 Global Stem Cell Therapy Market – By Geography
2. Stem Cell Therapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Stem Cell Therapy Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 South and Central America (SCAM) – PEST Analysis
4.2.5 Middle East and Africa PEST Analysis
4.3 Experts Opinion
5. Stem Cell Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management
5.1.2 Growing Prevalence of Cancer
5.2 Market Restraints
5.2.1 Availability of Illegal and Unapproved Products, and High Cost of Approved Treatments
5.3 Market Opportunities
5.3.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines
5.4 Future Trends
5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis
6. Stem Cell Therapy Market – Global Analysis
6.1 Global Stem Cell Therapy Market Revenue Forecast and Analysis
6.2 Global Stem Cell Therapy Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Stem Cell Therapy Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Adult Stem Cell Therapy
7.3.1 Overview
7.3.2 Adult Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Hematopoietic Stem Cell Therapy
7.3.3.1 Overview
7.3.3.2 Hematopoietic Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Umbilical Cord Stem Cell Therapy
7.3.4.1 Overview
7.3.4.2 Umbilical Cord Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Neuronal Stem Cell Therapy
7.3.5.1 Overview
7.3.5.2 Neuronal Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Mesenchymal Stem Cell
7.3.6.1 Overview
7.3.6.2 Mesenchymal Stem Cell: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Embryonic Stem Cell Therapy
7.4.1 Overview
7.4.2 Embryonic Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Induced Pluripotent Stem Cell Therapy
7.5.1 Overview
7.5.2 Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Other Stem Cell Therapy
7.6.1 Overview
7.6.2 Other Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Stem Cell Therapy Market Analysis and Forecasts to 2028 – by Treatment
8.1 Overview
8.2 Global Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
8.3 Allogeneic
8.3.1 Overview
8.3.2 Allogeneic: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Autologous
8.4.1 Overview
8.4.2 Autologous: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9. Global Stem Cell Therapy Market Analysis and Forecasts to 2028 – by Application
9.1 Overview
9.2 Global Stem Cell Therapy Market, by Application 2021 & 2028 (%)
9.3 Musculoskeletal
9.3.1 Overview
9.3.2 Musculoskeletal: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Dermatology
9.4.1 Overview
9.4.2 Dermatology: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Drug Discovery and Development
9.6.1 Overview
9.6.2 Drug Discovery and Development: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Other Applications
9.7.1 Overview
9.7.2 Other Applications: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10. Global Stem Cell Therapy Market – Revenue and Forecast to 2028 – by End User
10.1 Overview
10.2 Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
10.3 Academic & Research Institutes
10.3.1 Overview
10.3.2 Academic & Research Institutes: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Hospitals & Specialty Clinics
10.4.1 Overview
10.4.2 Hospitals & Specialty Clinics: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11. Stem Cell Therapy Market – Revenue and Forecast to 2028 – Geographic Analysis
11.1 North America: Stem Cell Therapy Market
11.1.1 Overview
11.1.2 North America: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3 North America: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.3.1 North America: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.4 North America: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.5 North America: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.6 North America: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.6.1 US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.6.1.1 Overview
11.1.6.1.2 US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.6.1.3 US: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.6.1.3.1 US: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.6.1.4 US: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.6.1.5 US: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.6.1.6 US: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.6.2 Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.6.2.1 Overview
11.1.6.2.2 Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.6.2.3 Canada: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.6.2.3.1 Canada: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.6.2.4 Canada: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.6.2.5 Canada: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.6.2.6 Canada: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.6.3 Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.6.3.1 Overview
11.1.6.3.2 Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.6.3.3 Mexico: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.6.3.3.1 Mexico: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.6.3.4 Mexico: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.6.3.5 Mexico: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.6.3.6 Mexico: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2 Europe: Stem Cell Therapy Market
11.2.1 Overview
11.2.2 Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.3.1 Europe: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.4 Europe: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.5 Europe: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.6 Europe: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2.7 Europe: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
11.2.7.1 Germany: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.3 Germany: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.7.1.3.1 Germany: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.7.1.4 Germany: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.7.1.5 Germany: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.7.1.6 Germany: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2.7.2 UK: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 UK: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.3 UK: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.7.2.3.1 UK: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.7.2.4 UK: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.7.2.5 UK: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.7.2.6 UK: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2.7.3 France: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 France: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.3 France: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.7.3.3.1 France: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.7.3.4 France: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.7.3.5 France: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.7.3.6 France: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2.7.4 Italy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.3 Italy: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.7.4.3.1 Italy: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.7.4.4 Italy: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.7.4.5 Italy: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.7.4.6 Italy: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2.7.5 Spain: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.3 Spain: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.7.5.3.1 Spain: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.7.5.4 Spain: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.7.5.5 Spain: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.7.5.6 Spain: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.2.7.6 Rest of Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.3 Rest of Europe: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.2.7.6.3.1 Rest of Europe: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.2.7.6.4 Rest of Europe: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.2.7.6.5 Rest of Europe: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.2.7.6.6 Rest of Europe: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.3 Asia Pacific: Stem Cell Therapy Market
11.3.1 Overview
11.3.2 Asia Pacific: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.3.1 Asia Pacific: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.4 Asia Pacific: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.5 Asia Pacific: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.6 Asia Pacific: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.3.7 Asia Pacific: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
11.3.7.1 China: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.1 China: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.2 China: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.7.1.2.1 China: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.7.1.3 China: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.7.1.4 China: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.7.1.5 China: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.3.7.2 Japan: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.1 Japan: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.2 Japan: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.7.2.2.1 Japan: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.7.2.3 Japan: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.7.2.4 Japan: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.7.2.5 Japan: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.3.7.3 India: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.1 India: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.2 India: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.7.3.2.1 India: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.7.3.3 India: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.7.3.4 India: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.7.3.5 India: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.3.7.4 South Korea: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.1 South Korea: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.2 South Korea: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.7.4.2.1 South Korea: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.7.4.3 South Korea: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.7.4.4 South Korea: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.7.4.5 South Korea: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.3.7.5 Australia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.1 Australia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.2 Australia: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.7.5.2.1 Australia: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.7.5.3 Australia: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.7.5.4 Australia: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.7.5.5 Australia: Stem Cell Therapy Market, by End User, 2019-2028 (USD Million)
11.3.7.6 Rest of Asia Pacific: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.1 Rest of Asia Pacific: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.2 Rest of Asia Pacific: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.3.7.6.2.1 Rest of Asia Pacific: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.3.7.6.3 Rest of Asia Pacific: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.3.7.6.4 Rest of Asia Pacific: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.3.7.6.5 Rest of Asia Pacific: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.4 Middle East & Africa: Stem Cell Therapy Market
11.4.1 Overview
11.4.2 Middle East & Africa: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
11.4.3 Middle East & Africa: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.4.3.1 Middle East & Africa: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.4.4 Middle East & Africa: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.4.5 Middle East & Africa: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.4.6 Middle East & Africa: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.4.7 Middle East & Africa: Stem Cell Therapy Market Share by Country – 2021 & 2028, (%)
11.4.7.1 Saudi Arabia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.1 Saudi Arabia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.2 Saudi Arabia: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.4.7.1.2.1 Saudi Arabia: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.4.7.1.3 Saudi Arabia: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.4.7.1.4 Saudi Arabia: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.4.7.1.5 Saudi Arabia: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.4.7.2 UAE: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.1 UAE: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.2 UAE: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.4.7.2.2.1 UAE: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.4.7.2.3 UAE: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.4.7.2.4 UAE: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.4.7.2.5 UAE: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.4.7.3 South Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.4.7.3.1 South Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.2 South Africa: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.4.7.3.2.1 South Africa: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.4.7.3.3 South Africa: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.4.7.3.4 South Africa: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.4.7.3.5 South Africa: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.4.7.4 Rest of Middle East and Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.4.7.4.1 Rest of Middle East and Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.4.2 Rest of Middle East and Africa: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.4.7.4.2.1 Rest of Middle East and Africa: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.4.7.4.3 Rest of Middle East and Africa: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.4.7.4.4 Rest of Middle East and Africa: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.4.7.4.5 Rest of Middle East and Africa: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.5 South and Central America: Stem Cell Therapy Market
11.5.1 Overview
11.5.2 South and Central America: Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
11.5.3 South and Central America: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.5.3.1 South and Central America: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.5.4 South and Central America: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.5.5 South and Central America: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.5.6 South and Central America: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.5.7 South and Central America: Stem Cell Therapy Market, by Country, 2021 & 2028(%)
11.5.7.1 Brazil: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.1 Brazil: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.1.2 Brazil: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.5.7.1.2.1 Brazil: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.5.7.1.3 Brazil: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.5.7.1.4 Brazil: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.5.7.1.5 Brazil: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.5.7.2 Argentina: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.1 Argentina: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.2.2 Argentina: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.5.7.2.2.1 Argentina: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.5.7.2.3 Argentina: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.5.7.2.4 Argentina: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.5.7.2.5 Argentina: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
11.5.7.3 Rest of South and Central America: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.1 Rest of South and Central America: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
11.5.7.3.2 Rest of South and Central America: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
11.5.7.3.2.1 Rest of South and Central America: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
11.5.7.3.3 Rest of South and Central America: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
11.5.7.3.4 Rest of South and Central America: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
11.5.7.3.5 Rest of South and Central America: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Stem Cell Therapy Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
12.5 South & Central America: Impact Assessment of COVID-19 Pandemic
13. Stem Cell Therapy Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Stem Cell Therapy Market (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 MEDIPOST
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 RichSource
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 BioTime, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Mesoblast Limited
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Holostem Terapie Avanzate Srl
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 U.S. Stem Cell, Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 TiGenix NV
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 AlloSource
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 NuVasive Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 JCR Pharmaceuticals Co. Ltd.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. US Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. UK Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 33. UK Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 34. UK Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 35. UK Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 36. France Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 37. France Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 38. France Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 39. France Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 40. France Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 41. Italy Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Italy Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 43. Italy Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 44. Italy Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 45. Italy Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. Spain Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 47. Spain Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 48. Spain Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 49. Spain Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 50. Spain Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 51. Rest of Europe Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Europe Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Europe Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Europe Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Europe Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 56. Asia Pacific Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 57. Asia Pacific Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 58. Asia Pacific Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 59. Asia Pacific Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 60. Asia Pacific Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 61. China Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 62. China Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 63. China Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 64. China Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 65. China Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 66. Japan Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 67. Japan Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 68. Japan Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 69. Japan Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 70. Japan Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 71. India Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 72. India Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 73. India Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 74. India Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 75. India Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 76. South Korea Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 77. South Korea Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 78. South Korea Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 79. South Korea Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 80. South Korea Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 81. Australia Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 82. Australia Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 83. Australia Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 84. Australia Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 85. Australia Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of Asia Pacific Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of Asia Pacific Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Asia Pacific Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Asia Pacific Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Asia Pacific Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 91. Middle East & Africa Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East & Africa Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East & Africa Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East & Africa Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East & Africa Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 96. Saudi Arabia Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 101. UAE Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 102. UAE Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 103. UAE Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 104. UAE Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 105. UAE Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 106. South Africa Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 111. Rest of Middle East and Africa Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East and Africa Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East and Africa Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East and Africa Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East and Africa Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 116. South and Central America Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 117. South and Central America Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 120. South and Central America Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 121. Brazil Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 126. Argentina Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 131. Rest of South and Central America Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South and Central America Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South and Central America Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South and Central America Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 136. Organic Developments in the Stem Cell Therapy Market
Table 137. Inorganic Developments in the Stem Cell Therapy Market
Table 138. Glossary of Terms
LIST OF FIGURES
Figure 1. Stem Cell Therapy Market Segmentation
Figure 2. Stem Cell Therapy Segmentation, By Region
Figure 3. Global Stem Cell Therapy Market Overview
Figure 4. Adult Stem Cell Therapy Segment Held Largest Share of Type Segment in Stem Cell Therapy Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Stem Cell Therapy Market, By Geography (US$ Million)
Figure 7. Global Stem Cell Therapy Market- Leading Country Markets (US$ Million)
Figure 8. Global Stem Cell Therapy Market – Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. South and Central America (SCAM) PEST Analysis
Figure 13. Middle East and Africa: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Stem Cell Therapy Market Impact Analysis of Drivers and Restraints
Figure 16. Global Stem Cell Therapy Market – Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Stem Cell Therapy Market – By Geography Forecast and Analysis – 2021- 2028
Figure 18. Market Positioning of Key Players In Global Stem Cell Therapy Market
Figure 19. Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
Figure 20. Adult Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Hematopoietic Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Umbilical Cord Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Neuronal Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Mesenchymal Stem Cell: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Embryonic Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other Stem Cell Therapy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Global Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
Figure 29. Allogeneic: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Autologous: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Global Stem Cell Therapy Market, by Application 2021 & 2028 (%)
Figure 32. Musculoskeletal: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Dermatology: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Cardiology: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Drug Discovery and Development: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Other Applications: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
Figure 38. Academic & Research Institutes: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Hospitals & Specialty Clinics: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. North America: Stem Cell Therapy Market, by Key Country – Revenue (2021) (US$ Million)
Figure 41. North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. North America: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
Figure 43. US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Europe: Stem Cell Therapy Market, by Key Country – Revenue (2021) (US$ Million)
Figure 47. Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Europe: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
Figure 49. Germany: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. UK: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. France: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Italy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Spain: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Rest of Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Asia Pacific: Stem Cell Therapy Market, by Key Country – Revenue (2021) (USD Million)
Figure 56. Asia Pacific Stem Cell Therapy Market Revenue and Forecast to 2028 (USD Million)
Figure 57. China: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Japan: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. India: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. South Korea: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. Australia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Rest of Asia Pacific: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. Middle East & Africa: Stem Cell Therapy Market, by Key Country – Revenue (2021) (USD Million)
Figure 64. Middle East & Africa Stem Cell Therapy Market Revenue and Forecast to 2028 (USD Million)
Figure 65. Middle East & Africa: Stem Cell Therapy Market Share by Country – 2021 & 2028, (%)
Figure 66. Saudi Arabia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. UAE: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. South Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 69. Rest of Middle East and Africa: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 70. South and Central America: Stem Cell Therapy Market, by Key Country – Revenue (2021) (USD Million)
Figure 71. South and Central America Stem Cell Therapy Market Revenue and Forecast to 2028 (USD Million)
Figure 72. South and Central America: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
Figure 73. Brazil: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 74. Argentina: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 75. Rest of South and Central America: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 76. Impact of COVID-19 Pandemic on North American Country Markets
Figure 77. Impact of COVID-19 Pandemic in European Country Markets
Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 79. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 80. Impact of COVID-19 Pandemic in South & Central America Country Markets
Figure 81. Growth Strategies in the Stem Cell Therapy Market (%)
The List of Companies - Stem Cell Therapy Market
- MEDIPOST
- RichSource
- BioTime, Inc.
- Mesoblast Limited
- Holostem Terapie Avanzate Srl
- U.S. Stem Cell, Inc.
- TiGenix NV
- AlloSource
- NuVasive Inc
- JCR Pharmaceuticals Co. Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Stem Cell Therapy Market
Feb 2023
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2023
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2023
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Feb 2023
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Feb 2023
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Feb 2023
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Feb 2023